Trial Profile
Pharmacokinetics, pharmacodynamics and safety of tenofovir alafenamide in HIV-1 infected patients.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 09 Apr 2014
Price :
$35
*
At a glance
- Drugs Tenofovir alafenamide (Primary) ; Tenofovir disoproxil fumarate
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacogenomic; Pharmacokinetics
- Sponsors Gilead Sciences
- 09 Apr 2014 New trial record
- 06 Feb 2014 Results published in the Journal of Antimicrobial Chemotherapy.